Bio-Techne Corporation TECH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.94% | -0.38% | 0.17% | 1.64% | 3.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.94% | -0.38% | 0.17% | 1.64% | 3.85% |
| Cost of Revenue | 2.96% | 0.40% | 0.77% | 1.32% | 2.15% |
| Gross Profit | -0.06% | -0.77% | -0.13% | 1.80% | 4.72% |
| SG&A Expenses | -8.65% | -10.78% | -11.26% | 6.87% | 12.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.38% | -5.59% | -4.79% | 4.39% | 7.94% |
| Operating Income | 20.37% | 22.89% | 22.65% | -8.74% | -11.25% |
| Income Before Tax | 113.94% | 144.44% | -9.72% | -38.54% | -39.72% |
| Income Tax Expenses | 95.82% | 134.69% | 20.00% | 19.64% | 10.57% |
| Earnings from Continuing Operations | 120.52% | 147.77% | -16.79% | -48.71% | -48.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 120.52% | 147.77% | -16.79% | -48.71% | -48.26% |
| EBIT | 20.37% | 22.89% | 22.65% | -8.74% | -11.25% |
| EBITDA | 10.91% | 11.58% | 11.83% | -7.96% | -9.22% |
| EPS Basic | 122.40% | 152.79% | -15.72% | -48.18% | -48.17% |
| Normalized Basic EPS | 18.90% | 23.28% | 26.97% | -2.81% | -6.26% |
| EPS Diluted | 125.37% | 153.49% | -17.33% | -49.48% | -48.92% |
| Normalized Diluted EPS | 19.04% | 23.76% | 28.05% | -1.80% | -5.36% |
| Average Basic Shares Outstanding | -0.18% | -0.88% | -1.53% | -1.35% | -0.80% |
| Average Diluted Shares Outstanding | -0.37% | -1.36% | -2.31% | -2.31% | -1.66% |
| Dividend Per Share | -25.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.55% | -0.60% | 0.18% | 0.92% | 0.92% |